Discontinuation report NOLVADEX-D TAB 20MG
| Report ID | 170947 |
| Drug Identification Number | 02048485 |
| Brand name | NOLVADEX-D TAB 20MG |
| Common or Proper name | tamoxifen citrate |
| Company Name | ASTRAZENECA CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | TAMOXIFEN |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 tablets |
| ATC code | L02BA |
| ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2023-03-21 |
| Actual discontinuation date | 2023-03-21 |
| Remaining supply date | 2023-03-21 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | All remaining stock has been sold. |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2023-03-22 | English | Compare |
| v11 | 2023-03-21 | French | Compare |
| v10 | 2023-03-21 | English | Compare |
| v9 | 2023-03-17 | French | Compare |
| v8 | 2023-03-17 | French | Compare |
| v7 | 2023-03-17 | English | Compare |
| v6 | 2023-03-08 | French | Compare |
| v5 | 2023-03-08 | English | Compare |
| v4 | 2022-10-03 | French | Compare |
| v3 | 2022-10-03 | English | Compare |
| v2 | 2022-10-03 | French | Compare |
| v1 | 2022-10-03 | English | Compare |
Showing 1 to 12 of 12